Download file, English (1 MB PDF) - RHO

Uganda HPV Vaccine Demonstration Project
A more comprehensive report on the HPV vaccine demonstration project described
in the next nine presentations can be found in the Results, Lessons Learnt, and
Recommendations report from the Uganda project, in the Resources section at the
end of this document.
HPV Vaccines: Evidence for Impact
Dr. Aisha Jumaan
Director, HPV Vaccines: Evidence for Impact Project
PATH
Dr. Aisha Jumaan described PATH’s work on cervical cancer prevention as comprehensive, including
both vaccination and screening activities. In discussing the HPV vaccine demonstration project, she
emphasized the participation of in-country MOH and research personnel in the decision-making and
implementation of the projects.
For this project, teams in four countries—India, Peru, Uganda, and Vietnam—assessed methods that
governments could use to implement HPV vaccination programs should they choose to add HPV vaccine
to their immunization schedules. The objectives of the overall project are the following:
• Generate critical data and experience for evidence-based decision-making, strengthening
essential health system capabilities, and creating a supportive social and political climate for
HPV vaccination programs in four countries.
• Leverage country introduction activities to inform and support global advocacy efforts, regional
HPV vaccine strategies, and country government introduction plans.
• Develop and disseminate strategic forecasts, investment cases, and decision-making tools to
inform and influence industry production capacity and pricing decisions, international agency
financing initiatives, and country government introduction.
Report of an African Regional Meeting on Cervical Cancer: September 2010 16